MINNEAPOLIS, May 31, 2024
/PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today
announced that Kim Kelderman,
President and Chief Executive Officer will present at the following
investor conferences:
William Blair 44th
Annual Growth Conference
June 4, 2024
9:20 AM CDT
Jefferies Global Healthcare Conference
June 6, 2024
9:30 AM EDT
Goldman Sachs 45th Annual Global Healthcare
Conference
June 11, 2024
9:20 AM EDT
A live webcast of the presentations can be accessed via the IR
Calendar page of Bio-Techne's Investor Relations website at
https://investors.bio-techne.com/ir-calendar.
About Bio-Techne
Bio-Techne Corporation (NASDAQ:
TECH) is a global life sciences company providing innovative tools
and bioactive reagents for the research and clinical diagnostic
communities. Bio-Techne products assist scientific investigations
into biological processes and the nature and progress of specific
diseases. They aid in drug discovery efforts and provide the means
for accurate clinical tests and diagnoses. With thousands of
products in its portfolio, Bio-Techne generated over $1.1 billion in net sales in fiscal 2023 and has
approximately 3,100 employees worldwide. For more information on
Bio-Techne and its brands, please
visit https://www.bio-techne.com or follow the Company on
social media
at: Facebook, LinkedIn, Twitter or YouTube.
|
Contact:
|
David Clair, Vice
President, Investor Relations & Corporate
Development
|
|
david.clair@bio-techne.com
|
|
612-656-4416
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-present-at-upcoming-investor-conferences-302157900.html
SOURCE Bio-Techne Corporation